Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Gonzalez
Boxuan Zhong
Edgar Lobaton

Showing results (221-230 of 329) with videos related to

Pageof 33
Sort By:
NPJ Vaccines|February 22, 2024
No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccinesAhmet Yalcinkaya, Marco Cavalli, Axel Cederholm, et al.
The Journal of Rheumatology|March 23, 2002
Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitisMonica Vazquez-Del Mercado, Araceli Garcia-Gonzalez, José Francisco Muñoz-Valle, et al.
Scientific Reports|August 23, 2017
Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuriaMarta Martin-Lorenzo, Laura Gonzalez-Calero, Paula J Martinez, et al.
Journal of Clinical Immunology|October 23, 2024
Normalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (Anifrolumab) in Patients with Type I InterferonopathiesGenia Kretzschmar, Laura Piñero Páez, Ziyang Tan, et al.
Scientific Reports|March 4, 2018
Author Correction: Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuriaMarta Martin-Lorenzo, Laura Gonzalez-Calero, Paula J Martinez, et al.
Cell Death Discovery|April 25, 2025
The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos SyndromeRamla Omar, Michelle Aw Lee, Laura Gonzalez-Trueba, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 15, 2015
Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomesIrene Zubiri, Maria Posada-Ayala, Alberto Benito-Martin, et al.
Journal of Immunology Research|May 8, 2014
Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritisLaura Gonzalez-Lopez, Alberto Daniel Rocha-Muñoz, Manuel Ponce-Guarneros, et al.
International Journal of Molecular Sciences|May 14, 2025
Genetic Variants of the <i>ATIC</i> Gene and Therapeutic Response to Methotrexate in Patients with Rheumatoid ArthritisSergio Gabriel Gallardo-Moya, Laura Gonzalez-Lopez, Betsabe Contreras-Haro, et al.
ACS Chemical Neuroscience|February 6, 2013
Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase/butyrylcholinesterase inhibitors: effect against amyloid-β-induced neurotoxicityDaniel Silva, Mourad Chioua, Abdelouahid Samadi, et al.
Pageof 33

Showing results (221-230 of 329) with videos related to

Sort By:
Pageof 33
NPJ Vaccines|February 22, 2024
No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccinesAhmet Yalcinkaya, Marco Cavalli, Axel Cederholm, et al.
The Journal of Rheumatology|March 23, 2002
Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitisMonica Vazquez-Del Mercado, Araceli Garcia-Gonzalez, José Francisco Muñoz-Valle, et al.
Scientific Reports|August 23, 2017
Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuriaMarta Martin-Lorenzo, Laura Gonzalez-Calero, Paula J Martinez, et al.
Journal of Clinical Immunology|October 23, 2024
Normalized Interferon Signatures and Clinical Improvements by IFNAR1 Blocking Antibody (Anifrolumab) in Patients with Type I InterferonopathiesGenia Kretzschmar, Laura Piñero Páez, Ziyang Tan, et al.
Scientific Reports|March 4, 2018
Author Correction: Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuriaMarta Martin-Lorenzo, Laura Gonzalez-Calero, Paula J Martinez, et al.
Cell Death Discovery|April 25, 2025
The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos SyndromeRamla Omar, Michelle Aw Lee, Laura Gonzalez-Trueba, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 15, 2015
Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomesIrene Zubiri, Maria Posada-Ayala, Alberto Benito-Martin, et al.
Journal of Immunology Research|May 8, 2014
Anti-cyclic citrullinated peptide (anti-CCP) and anti-mutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritisLaura Gonzalez-Lopez, Alberto Daniel Rocha-Muñoz, Manuel Ponce-Guarneros, et al.
International Journal of Molecular Sciences|May 14, 2025
Genetic Variants of the <i>ATIC</i> Gene and Therapeutic Response to Methotrexate in Patients with Rheumatoid ArthritisSergio Gabriel Gallardo-Moya, Laura Gonzalez-Lopez, Betsabe Contreras-Haro, et al.
ACS Chemical Neuroscience|February 6, 2013
Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase/butyrylcholinesterase inhibitors: effect against amyloid-β-induced neurotoxicityDaniel Silva, Mourad Chioua, Abdelouahid Samadi, et al.
Pageof 33